Finance

Beta
Lists
ADPT:NASDAQ
Adaptive Biotechnologies Corp
$16.90
-6.53%
(-1.18) 1D
$16.91
+0.06% (+0.010)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADPT...
Open
$17.90
High
$18.29
Low
$16.68
Mkt. cap
2.70B
Avg. vol.
1.77M
Volume
2.16M
52-wk high
$20.74
52-wk low
$9.90
EPS
-$0.33
Beta
2.16
Shares outstanding
160.04M
No. of employees
624
Open
$17.90
High
$18.29
Low
$16.68
Mkt. cap
2.70B
Avg. vol.
1.77M
Volume
2.16M
52-wk high
$20.74
52-wk low
$9.90
EPS
-$0.33
Beta
2.16
Shares outstanding
160.04M
No. of employees
624
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to ADPT in the past 3 months
Strong Buy
Buy
7
Hold
1
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ADPT in the last 3 months.
Highest
Current $16.90
$22.00 (+30.18%)
Average
$20.17 (+19.35%)
Lowest
$18.00 (+6.51%)
News stories
From sources across the web
About Adaptive Biotechnologies Corp
CEOChad Robins
Employees624
Founded2009
HeadquartersSeattle, Washington, United States
SectorHealth care
Websiteadaptivebiotech.com
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.13 / -$0.16
+21.21%beat
Revenue / Est. (USD)
70.87M / 60.96M
+16.27%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
58.88M
93.97M
71.68M
70.87M
Cost of goods sold
42.13M
41.83M
39.99M
42.33M
Cost of revenue
42.13M
41.83M
39.99M
42.33M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.36M
41.43M
44.04M
47.33M
Operating expense
41.78M
41.86M
44.47M
47.75M
Total operating expenses
83.92M
83.68M
84.45M
90.08M
Operating income
-25.04M
10.29M
-12.77M
-19.21M
Other non operating income
-
-
-
-
EBT including unusual items
-25.59M
9.54M
-13.58M
-20.02M
EBT excluding unusual items
-25.59M
9.54M
-13.87M
-20.15M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-25.61M
9.55M
-13.58M
-20.03M
Net profit margin
-43.50%
10.16%
-18.94%
-28.27%
Earnings per share
-0.17
0.06
-0.09
-0.13
Interest and investment income
2.39M
2.23M
1.86M
1.94M
Interest expense
-2.95M
-2.97M
-2.95M
-2.89M
Net interest expenses
-557.00K
-745.00K
-1.09M
-945.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.53M
14.70M
-8.58M
-15.37M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer